Matinas BioPharma Holdings Inc (MTNB)
0.1711
0.00 (0.00%)
USD |
NYAM |
May 17, 16:00
0.1741
0.00 (0.00%)
After-Hours: 20:00
Matinas BioPharma Holdings Total Liabilities (Quarterly): 5.052M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 5.052M |
| December 31, 2023 | 5.858M |
| September 30, 2023 | 6.641M |
| June 30, 2023 | 6.171M |
| March 31, 2023 | 5.637M |
| December 31, 2022 | 8.182M |
| September 30, 2022 | 8.927M |
| June 30, 2022 | 9.567M |
| March 31, 2022 | 8.103M |
| December 31, 2021 | 8.832M |
| September 30, 2021 | 8.731M |
| June 30, 2021 | 7.068M |
| March 31, 2021 | 5.794M |
| December 31, 2020 | 7.237M |
| September 30, 2020 | 6.601M |
| June 30, 2020 | 6.262M |
| March 31, 2020 | 6.51M |
| December 31, 2019 | 7.189M |
| September 30, 2019 | 6.835M |
| June 30, 2019 | 7.796M |
| March 31, 2019 | 7.566M |
| Date | Value |
|---|---|
| December 31, 2018 | 3.802M |
| September 30, 2018 | 4.112M |
| June 30, 2018 | 3.517M |
| March 31, 2018 | 3.056M |
| December 31, 2017 | 3.742M |
| September 30, 2017 | 3.739M |
| June 30, 2017 | 2.592M |
| March 31, 2017 | 3.172M |
| December 31, 2016 | 2.666M |
| September 30, 2016 | 2.585M |
| June 30, 2016 | 2.567M |
| March 31, 2016 | 2.525M |
| December 31, 2015 | 2.334M |
| September 30, 2015 | 2.908M |
| June 30, 2015 | 3.233M |
| March 31, 2015 | 3.405M |
| December 31, 2014 | 1.134M |
| September 30, 2014 | 1.043M |
| June 30, 2014 | 0.9058M |
| March 31, 2014 | 0.717M |
| December 31, 2013 | 0.859M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.052M
Minimum
Mar 2024
9.567M
Maximum
Jun 2022
7.150M
Average
6.952M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.61M |
| Shareholders Equity (Quarterly) | 14.56M |